coenzyme Q10/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
Decreases interleukin-6 concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Findingreplicated ×1“At the end of study, compared with pldacebo, CoQ10 supplementation resulted in significant decreases in serum levels of TNF-α (p = 0.009), hs-CRP and IL-6 (p = 0.001, p = 0.007, respectively).”
Quoted verbatim from The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.. - Study
- RCT
- Duration
- 8 weeks
- Dose
- 200 mg CoQ10 capsules per day, 8 weeks
- Population
- Overweight and obese women with polycystic ovary syndrome (PCOS)
The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.2021PMID:32544011Permalink
Keep reading
- Everything the graph holds on coenzyme Q10
- Every compound studied against Interleukin-6 concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M2PFCQ51F1VY7B1A493H3TAK